简化协议与全协议乳腺MRI诊断效能的比较:系统综述与Meta分析
该系统综述与Meta分析纳入11项研究(1项前瞻性、10项回顾性),比较简化乳腺MRI(AB-MRI)与全协议MRI(FP-MRI)的诊断效能。FP-MRI敏感度为95%,AB-MRI为86%,差异有统计学意义(P = .005);特异度差异无统计学意义(P = .50)。作者认为FP-MRI仍是乳腺癌检测的金标准,AB-MRI在高危筛查中可提供更快的替代方案,但其较低敏感度限制了其作为独立诊断工具的使用。
要点
- FP-MRI敏感度95%,AB-MRI敏感度86%,两者差异有统计学意义(P = .005)。
- AB-MRI与FP-MRI特异度差异无统计学意义(P = .50)。
- AB-MRI在检测小病灶和非肿块强化方面仍存在挑战。
核心结论
- FP-MRI仍是乳腺癌检测的金标准,AB-MRI在高危筛查中可提供更快的替代方案,但其较低敏感度限制了其作为独立诊断工具的使用。
研究设计与样本
- 系统综述与Meta分析,检索时间段为2019年11月至2022年12月,纳入11项研究(1项前瞻性、10项回顾性),采用双变量模型计算敏感度和特异度的汇总估计值。
诊断标准与关键数值
- FP-MRI敏感度95% vs AB-MRI敏感度86%,差异有统计学意义(P = .005);两者特异度差异无统计学意义(P = .50)。
临床应用与阅片要点
- AB-MRI采集时间较短,可能提高患者流通量,但在检测小病灶和非肿块强化方面仍存在挑战;部分研究建议增加弥散加权成像等额外序列以提高诊断性能。
局限性
- 纳入的11项研究中仅1项为前瞻性研究,10项为回顾性研究。
- 未来研究应优化AB-MRI协议并考虑患者特异性因素,以改善乳腺癌筛查和诊断策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This meta-analysis compares the efficacy, limitations, and clinical implications of abbreviated breast MRI (AB-MRI) and full protocol MRI (FP-MRI), focusing on diagnostic accuracy across diverse populations. It extends previous analyses by including studies conducted after 2019 in both screening and diagnostic contexts.
METHODS: We conducted a systematic review (November 2019 to December 2022), using a bivariate model to calculate summary estimates of sensitivity and specificity. Random effect models were applied for summary area under the curve (AUC), and probability distributions for negative and positive predictive values were obtained. Subgroup analyses explored differences in sensitivity, specificity, and AUC between AB-MRI and FP-MRI.
RESULTS: From 11 eligible studies (1 prospective, 10 retrospective), statistical analysis revealed a significant difference in sensitivity between FP-MRI (95%) and AB-MRI (86%, P = .005), with no significant difference in specificity (P = .50). AB-MRI's shorter acquisition time suggests potential for higher patient throughput, but challenges remain in detecting small lesions and nonmass enhancements. Some studies recommend additional sequences, like diffusion-weighted imaging, to improve diagnostic performance.
CONCLUSIONS: While FP-MRI remains the gold standard in breast cancer detection, AB-MRI offers a quicker alternative, especially in high-risk screening. However, its lower sensitivity limits its use as a standalone diagnostic tool. Future research should optimize AB-MRI protocols and consider patient-specific factors to enhance breast cancer screening and diagnostic strategies.
ADVANCES IN KNOWLEDGE: This meta-analysis expands understanding of AB-MRI's role in breast cancer detection, highlighting its benefits and limitations compared to FP-MRI, particularly in terms of sensitivity and screening efficiency.
引用
- Pesapane F, Battaglia O, Rotili A, et al. Comparative diagnostic efficacy of abbreviated and full protocol breast MRI: a systematic review and a meta-analysis. Br J Radiol. 2024. PMID: 39400335. doi:10.1093/bjr/tqae196
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。